Title
Author
DOI
Article Type
Special Issue
Volume
Issue
60Cobalt vs. linear accelerator in the treatment of locally advanced cervix carcinoma: a comparison of survival and recurrence patterns
1Division of Gynecologic Oncology, Department(!{ Obstetrics and Gynecology, Kings County Hospital and State University of New York-Health Science Center at Brooklyn, New York, USA
*Corresponding Author(s): K. Holcomb E-mail:
Objective: To compare the survival and recurrence patterns of patients with locally advanced cervical carcinoma treated with 60cobalt radiotherapy units and linear accelerators.
Methods: Two hundred and forty-eight patients with cervical carcinoma stages IIB-IVA who were treated with primary irradiation between the years 1985 and 1988 comprised the study group. The median survival of patients treated with 60cobalt units and linear accelerators was calculated using the method of Kaplan and Meier and compared using the log-rank test. Recurrence patterns were compared using chi-square analysis; p < .05 was considered significant for all tests.
Results: One hundred and ninety-five patients were treated with 60cobalt units (Group 1) and 53 patients were treated with a linear accelerator (Group 2). Group 1 and 2 were similar with regard to mean age and weight, stage distribution, and mean dose to point A. The rate of recurrence was comparable between Group 1 and 2 (65.6% vs. 64.2%) and no significant difference was found in overall survival between the groups (20 months vs. 21 months. p = 81). There was a trend toward increasing pelvic recurrence in Group 1 (50.8%) compared to Group 2 (35.8%, p = .08).
Conclusions: 60Cobalt units and linear accelerators offer comparable rates of overall survival in patients with locally advanced cervix carcinoma.
Cervical carcinoma; 6°Cobalt; Linear Accelerator; Survival
K. Holcomb,N. Gabbur,T. Tucker,R. P. Matthews,Y. C. Lee,O. Abolafia. 60Cobalt vs. linear accelerator in the treatment of locally advanced cervix carcinoma: a comparison of survival and recurrence patterns. European Journal of Gynaecological Oncology. 2001. 22(1);16-19.
[1] Wingo P.A., Tong T., Bolden S.: "Cancer Statistics". C. A. Cancer J. Clin., I 995, 45, 8.
[2] Karzrnark C. J., Nunan C. S., Tanabe E.: "Medical electron acccIerators". New York, McGraw-Hill, 1993.
[3] Karzmark C. J., Pering N. C.: "Electron linear accelerators for radiation therapy: history, principles, and contemporary developments". Phys. Med. Biol., 1973, 18, 321.
[4] Perez C. A., Purdy J. A., Korba A., Powers W. E.: "High-energy X-ray beams in the management of head and neck and pelvic cancers". In: Kramer S., ed. "High Energy Photons and Electrans". New York,J ohn Wiley,1976, 215.
[5] Allt W. E. C.: "Supervoltage radiation treatment in advanced cancer of the uterine cervix". Canad Med. Ass. J., 1969, 100, 792.
[6] Hanks G. E., Diamond J. J., Kramer S.: "The need for complex technology in radiation oncology. Correlation of facility characte ristics and structure with outcome". Cancer, 1985 May 1, 55 (Suppl. 9), 2198.
[7] Kaplan E. L., Meier P.: "Nonparametric estimation from mcomplete obserrvations". J. Amer. Statist. Assoc., 1958, 53, 457.
[8] Montana G. S., Hanlon A. L., Brickner T. J., Owen J. B., Hanks G. E., Ling C. C., Komaki R. et al.: "Carcinoma of the cervix: patterns of care studies: review of 1978, 1983, and 1988-1989 surveys". Int. J. Radial. Biol. Phys., 1995, Jul. 30, 32 (5), 1481.
[9] Bush R. F.: "Malignancies of the Ovary, Uterus, and Cervix" London, Edward Arnold, 1979.
[10] Johns E. H.:'The Physics of Radiology". (4th Ed山on) Spring fieId, Illinois, Charles C. Thomas Publisher, 183, 714.
[11] Hreshchyshyn M.,A ron B.,B oronow R.,F ranklin E.W. 3 d, Shingleton H. M., Blessing J. A.: "Hydroxyurea or placebo combined with radiation to treat stage IIB and IV cervical cancer confined to the pelvis". Int. J. Radial. Oncol. Biol. Phys.,1985, 5 ,317.
Top